MAPT and Alzheimer disease: We combined for the first time high-resolution MRI-assessed mapping of myelin, resting-state fMRI functional connectomics, and subject-level tau-PET imaging in two independent samples of deeply characterized elderly individuals with biomarker evidence of AD.